1. Home
  2. CPRX vs SOC Comparison

CPRX vs SOC Comparison

Compare CPRX & SOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • SOC
  • Stock Information
  • Founded
  • CPRX 2002
  • SOC 2020
  • Country
  • CPRX United States
  • SOC United States
  • Employees
  • CPRX N/A
  • SOC N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • SOC
  • Sector
  • CPRX Health Care
  • SOC
  • Exchange
  • CPRX Nasdaq
  • SOC Nasdaq
  • Market Cap
  • CPRX 2.6B
  • SOC 2.8B
  • IPO Year
  • CPRX 2006
  • SOC N/A
  • Fundamental
  • Price
  • CPRX $20.02
  • SOC $24.49
  • Analyst Decision
  • CPRX Strong Buy
  • SOC Buy
  • Analyst Count
  • CPRX 5
  • SOC 3
  • Target Price
  • CPRX $33.20
  • SOC $30.00
  • AVG Volume (30 Days)
  • CPRX 1.5M
  • SOC 4.2M
  • Earning Date
  • CPRX 11-05-2025
  • SOC 11-13-2025
  • Dividend Yield
  • CPRX N/A
  • SOC N/A
  • EPS Growth
  • CPRX 183.96
  • SOC N/A
  • EPS
  • CPRX 1.65
  • SOC N/A
  • Revenue
  • CPRX $558,499,000.00
  • SOC N/A
  • Revenue This Year
  • CPRX $16.51
  • SOC N/A
  • Revenue Next Year
  • CPRX $9.58
  • SOC $184.34
  • P/E Ratio
  • CPRX $12.10
  • SOC N/A
  • Revenue Growth
  • CPRX 28.55
  • SOC N/A
  • 52 Week Low
  • CPRX $19.15
  • SOC $16.26
  • 52 Week High
  • CPRX $26.58
  • SOC $35.00
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 46.35
  • SOC 48.44
  • Support Level
  • CPRX $19.66
  • SOC $21.75
  • Resistance Level
  • CPRX $20.52
  • SOC $24.48
  • Average True Range (ATR)
  • CPRX 0.67
  • SOC 1.93
  • MACD
  • CPRX 0.03
  • SOC -0.04
  • Stochastic Oscillator
  • CPRX 42.08
  • SOC 59.10

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

About SOC Sable Offshore Corp. Common Stock

Sable Offshore Corp is a Houston-based independent upstream company focused on responsibly developing the prolific Santa Ynez Unit in federal waters offshore California. The company is managed as one reportable segment, oil and gas.

Share on Social Networks: